US EditionArrowhead Shares Bumpy After Partner Troubles - Los Angeles Business Journal
Summary by labusinessjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Arrowhead Shares Bumpy After Partner Troubles - Los Angeles Business Journal
When Pasadena-based Arrowhead Pharmaceuticals Inc. signed a huge licensing and collaboration deal with Cambridge, Massachusetts-based Sarepta Therapeutics Inc. just before Thanksgiving last year, it seemed like a major lifeline for the company in its long quest to bring to market drugs from its platform that combat diseases by silencing the genes that cause them. The deal involved Sarepta paying Arrowhead $500 million in cash up front with anoth…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
